Case Western Reserve-led research team identifies biomarker to identify which patients with oropharyngeal cancer will benefit from therapy ‘de-escalation
CLEVELAND—A Case Western Reserve University-led team of scientists has used Artificial Intelligence (AI) to identify which patients with certain head and neck cancers would benefit from reducing the intensity of treatments such as radiation therapy and chemotherapy.